News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
39,219 Results
Type
Article (2510)
Company Profile (40)
Press Release (36665)
Multimedia
Podcasts (7)
Webinars (2)
Section
Business (14165)
Career Advice (78)
Deals (2089)
Drug Delivery (9)
Drug Development (4125)
Employer Resources (10)
FDA (434)
Job Trends (775)
News (20206)
Policy (1053)
Tag
Academia (144)
Allergies (7)
Alliances (3490)
ALS (4)
Alzheimer's disease (51)
Antibody-drug conjugate (ADC) (20)
Approvals (433)
Artificial intelligence (18)
Autoimmune disease (3)
Automation (1)
Bankruptcy (12)
Best Places to Work (475)
BIOSECURE Act (2)
Biosimilars (14)
Biotechnology (29)
Bladder cancer (8)
Brain cancer (6)
Breast cancer (29)
Cancer (238)
Cardiovascular disease (7)
Career advice (64)
Career pathing (1)
CAR-T (22)
Cell therapy (62)
Cervical cancer (2)
Clinical research (3311)
Collaboration (147)
Company closure (2)
Compensation (77)
COVID-19 (181)
CRISPR (10)
C-suite (62)
Cystic fibrosis (5)
Data (253)
Denatured (6)
Depression (8)
Diabetes (15)
Diagnostics (474)
Digital health (1)
Diversity (2)
Diversity, equity & inclusion (1)
Drug discovery (20)
Drug pricing (8)
Duchenne muscular dystrophy (23)
Earnings (4398)
Editorial (3)
Employer branding (1)
Employer resources (8)
Events (6230)
Executive appointments (120)
FDA (527)
Funding (113)
Gene editing (23)
Gene therapy (32)
GLP-1 (61)
Government (152)
Guidances (21)
Healthcare (707)
Huntington's disease (4)
IgA nephropathy (9)
Immunology and inflammation (28)
Immuno-oncology (5)
Indications (3)
Infectious disease (189)
Inflammatory bowel disease (14)
Inflation Reduction Act (6)
Influenza (7)
Intellectual property (16)
Interviews (7)
IPO (1000)
IRA (7)
Job creations (292)
Job search strategy (62)
Kidney cancer (6)
Labor market (10)
Layoffs (47)
Leadership (1)
Legal (213)
Liver cancer (6)
Longevity (1)
Lung cancer (24)
Lymphoma (8)
Management (4)
Manufacturing (33)
MASH (7)
Medical device (310)
Medtech (310)
Mergers & acquisitions (1184)
Metabolic disorders (48)
Multiple sclerosis (16)
Neurodegenerative disease (19)
Neuropsychiatric disorders (5)
Neuroscience (127)
NextGen: Class of 2025 (352)
Non-profit (154)
Now hiring (8)
Obesity (22)
Opinion (16)
Ovarian cancer (16)
Pain (16)
Pancreatic cancer (14)
Parkinson's disease (7)
Partnered (2)
Patents (39)
Patient recruitment (13)
Peanut (1)
People (5764)
Pharmaceutical (5)
Phase I (1420)
Phase II (1651)
Phase III (883)
Pipeline (193)
Policy (14)
Postmarket research (30)
Preclinical (625)
Press Release (2)
Prostate cancer (6)
Psychedelics (2)
Radiopharmaceuticals (13)
Rare diseases (38)
Real estate (423)
Recruiting (5)
Regulatory (846)
Reports (7)
Research institute (144)
Resumes & cover letters (9)
RNA editing (5)
Schizophrenia (15)
Series A (32)
Series B (14)
Service/supplier (2)
Sickle cell disease (2)
Special edition (3)
Spinal muscular atrophy (2)
Sponsored (1)
Startups (496)
Stomach cancer (2)
Supply chain (4)
The Weekly (1)
Vaccines (40)
Venture capital (11)
Weight loss (15)
Women's health (3)
Worklife (1)
Date
Today (18)
Last 7 days (46)
Last 30 days (183)
Last 365 days (2468)
2025 (1780)
2024 (2610)
2023 (2858)
2022 (3750)
2021 (4048)
2020 (3471)
2019 (2061)
2018 (1554)
2017 (1795)
2016 (1624)
2015 (1833)
2014 (1369)
2013 (1188)
2012 (1396)
2011 (1332)
2010 (1181)
Location
Africa (44)
Alabama (2)
Arizona (16)
Asia (1908)
Australia (302)
California (1268)
Canada (192)
China (58)
Colorado (33)
Connecticut (13)
Delaware (4)
Europe (3926)
Florida (52)
Georgia (11)
Hawaii (2)
Idaho (3)
Illinois (17)
India (1)
Indiana (40)
Japan (12)
Kansas (14)
Kentucky (1)
Maryland (34)
Massachusetts (440)
Michigan (12)
Minnesota (19)
Mississippi (1)
Missouri (4)
Nebraska (1)
Nevada (3)
New Hampshire (2)
New Jersey (105)
New York (64)
North Carolina (113)
Northern California (578)
Ohio (33)
Oklahoma (2)
Oregon (5)
Pennsylvania (79)
Rhode Island (2)
South America (40)
South Carolina (1)
Southern California (525)
Tennessee (3)
Texas (116)
United States (2522)
Utah (3)
Virginia (7)
Washington D.C. (1)
Washington State (73)
West Virginia (1)
Wisconsin (8)
39,219 Results for "ideaya biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
IDEAYA Biosciences to Participate in Upcoming September 2025 Investor Relations Events
August 25, 2025
·
2 min read
Press Releases
Servier and IDEAYA Biosciences Partner to Bring Darovasertib, a Promising Uveal Melanoma Treatment, to Patients Worldwide
September 2, 2025
·
8 min read
Press Releases
IDEAYA Biosciences Announces Positive Interim Phase 2 Data for Darovasertib in the Neoadjuvant Setting of Primary Uveal Melanoma
September 8, 2025
·
6 min read
Press Releases
IDEAYA Biosciences to Participate in Upcoming July 2025 Investor Relations Event
July 21, 2025
·
2 min read
Press Releases
IDEAYA Biosciences Announces Agenda for 10-Year Anniversary R&D Day on September 8, 2025
August 18, 2025
·
3 min read
Press Releases
IDEAYA Biosciences, Inc. Reports Second Quarter 2025 Financial Results and Provides Business Update
August 6, 2025
·
13 min read
Press Releases
IDEAYA Biosciences Announces IND Submission for IDE892, a Potential Best-In-Class PRMT5 Inhibitor for MTAP-Deletion Solid Tumors
September 3, 2025
·
4 min read
Press Releases
IDEAYA Biosciences to Present First Median Overall Survival Data from Phase 2 Trial of the Darovasertib / Crizotinib Combination in Metastatic Uveal Melanoma at the 2025 Society for Melanoma Research Congress
September 1, 2025
·
3 min read
Press Releases
IDEAYA Biosciences to Participate in Upcoming June 2025 Investor Relations Events
June 2, 2025
·
2 min read
Cancer
Servier Commits up to $530M Into Eye Cancer Deal With IDEAYA
The French giant is gaining access to darovasertib, a small molecule protein kinase C inhibitor already in Phase II/III trials, with rights for the whole world besides the U.S.
September 2, 2025
·
2 min read
·
Dan Samorodnitsky
1 of 3,922
Next
